Author: GlobeNewswire

MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today releases details of…

– Toripalimab plus chemotherapy met primary endpoint with significant improvement in PFS compared to chemotherapy alone – – Data support…

BOSTON, Aug. 18, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development…

CAMBRIDGE, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (Nasdaq: MRSN), a clinical-stage biopharmaceutical company focused on discovering…

NEW HAVEN, Conn., Aug. 18, 2021 (GLOBE NEWSWIRE) — BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a pre-clinical,…

WATERTOWN, Mass., Aug. 18, 2021 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock…

Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1, 2 In the U.S., approximately…

COPENHAGEN, Denmark – August 18, 2021 – Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) will announce its 2021 first half…

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) —…

CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) — Cosmos Holdings, Inc. (“the Company”) (OTCQX: COSM), an international pharmaceutical company with a…